Related Experiment Video
Updated: Dec 2, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Subsequent Primary Neoplasms: Risks, Risk Factors, Surveillance, and Future Research
Michael Hawkins1, Smita Bhatia2, Tara O Henderson3
1Epidemiology & Director of Centre, Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Robert Aitken Building, Birmingham B15 2TY, UK.
Childhood cancer survivors face increased risks of subsequent primary neoplasms. This update reviews survivor cohorts, treatment effects like radiotherapy and chemotherapy, and genomics to inform future research and improve surveillance strategies.
Area of Science:
- Oncology
- Cancer Survivorship Research
- Genetics and Genomics
Background:
- Childhood cancer survivors are at a higher risk for developing secondary cancers later in life.
- Understanding these risks is crucial for long-term health management and improved patient outcomes.
- Existing research highlights the need for updated knowledge on risk factors and surveillance.
Purpose of the Study:
- To provide a concise update on recent advancements in understanding subsequent primary neoplasms in childhood cancer survivors.
- To summarize established and emerging large-scale survivor cohorts and their reported risks.
- To outline future research priorities in this field.
Main Methods:
- Review and synthesis of recent scientific literature and large-scale cohort studies.
- Analysis of data concerning radiotherapy and chemotherapy effects on secondary cancer development.
- Examination of survivor genomics as a risk determinant for subsequent neoplasms.
Main Results:
- Recent evidence confirms the significant role of treatments like radiotherapy and chemotherapy in secondary cancer risk.
- Genomic factors in survivors are increasingly recognized as contributors to subsequent primary neoplasm development.
- Comparisons between childhood and adolescent/young adult survivor cohorts reveal distinct risk profiles.
Conclusions:
- Continued research and updated surveillance guidelines are essential for managing long-term risks in childhood cancer survivors.
- Personalized risk assessment, incorporating treatment history and genomics, is key to optimizing follow-up care.
- Future research should focus on refining surveillance protocols and understanding the biological underpinnings of secondary cancers.
Related Concept Videos
Cancer Prevention
Some...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

